VSports手机版 - From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
- PMID: 20348957
- DOI: 10.1038/ng.557
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
Abstract (VSports app下载)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of motor neurons. Using unbiased transcript profiling in an ALS mouse model, we identified a role for the co-stimulatory pathway, a key regulator of immune responses. Furthermore, we observed that this pathway is upregulated in the blood of 56% of human patients with ALS. A therapy using a monoclonal antibody to CD40L was developed that slows weight loss, delays paralysis and extends survival in an ALS mouse model. This work demonstrates that unbiased transcript profiling can identify cellular pathways responsive to therapeutic intervention in a preclinical model of human disease VSports手机版. .
V体育安卓版 - References
-
- PLoS One. 2008 Jul 23;3(7):e2740 - PubMed
-
- Immunol Today. 1992 Nov;13(11):431-3 - PubMed
-
- Neuropathol Appl Neurobiol. 1990 Oct;16(5):401-10 - PubMed (V体育安卓版)
-
- Nat Rev Drug Discov. 2004 Aug;3(8):711-5 - PubMed
-
- Muscle Nerve. 1992 May;15(5):568-75 - V体育官网入口 - PubMed
Publication types
MeSH terms
- Actions (V体育官网入口)
- Actions (VSports app下载)
- Actions (VSports手机版)
- "V体育官网入口" Actions
- V体育2025版 - Actions
- "V体育平台登录" Actions
- V体育官网 - Actions
- Actions (VSports手机版)
- Actions (V体育安卓版)
- "V体育ios版" Actions
- "VSports手机版" Actions
- V体育安卓版 - Actions
- "VSports在线直播" Actions
- VSports最新版本 - Actions
Substances
- Actions (V体育官网入口)
- Actions (V体育官网入口)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases (VSports最新版本)
Miscellaneous